Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
This trial is conducted in the United States of America (USA). The purpose of this study is
 to determine if the use of insulin detemir in combination with insulin aspart is safe and at
 least as effective as insulin glargine in combination with insulin aspart for the control of
 blood glucose in patients with Type 2 diabetes.
Inclusion Criteria:

 -  Type 2 Diabetes for more than 12 months

 -  Currently treated with glucose lowering tablets or insulin

 -  HbA1c: 7.0-12.0%